Analyst Activity – Wells Fargo & Co Raises Its Price Target On Abbott Laboratories (NYSE:ABT) to $70.00

ME Staff
-
0

Analyst Ratings For Abbott Laboratories (NYSE:ABT)

Today, Wells Fargo & Co raised its price target on Abbott Laboratories (NYSE:ABT) to $70.00 per share.

Some recent analyst ratings include

  • 1/25/2018-BMO Capital Markets Reiterated Rating of Outperform .
  • 1/25/2018-William Blair Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 1/22/2018-BTIG Research was Downgraded by analysts at BTIG Research from a “Buy ” rating to a ” Neutral” rating.
  • 1/19/2018-Leerink Swann Reiterated Rating of Market Perform.

Dividend information for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) pays an annual dividend of $1.12 with a yield of 1.79% and an average dividend growth of 6.40% based on a 3 Year Average..

Dividend History for Abbott Laboratories (NYSE:ABT)

  • On 12/15/2017 Abbott Laboratories announced a quarterly dividend of $0.28 1.99% with an ex dividend date of 1/11/2018 which will be payable on 2/15/2018.
  • On 9/15/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.05% with an ex dividend date of 10/12/2017 which will be payable on 11/15/2017.
  • On 6/9/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.25% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
  • On 2/17/2017 Abbott Laboratories announced a quarterly dividend of $0.27 2.36% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
  • On 12/9/2016 Abbott Laboratories announced a quarterly dividend of $0.27 2.7% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
  • On 9/15/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.48% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.
  • On 6/10/2016 Abbott Laboratories announced a quarterly dividend of $0.26 2.75% with an ex dividend date of 7/13/2016 which will be payable on 8/15/2016.

Recent Insider Trading Activity For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) has insider ownership of 0.76% and institutional ownership of 71.21%.

  • On 12/14/2017 Daniel Gesua Sive Salvadori, Insider, sold 28,319 with an average share price of $54.92 per share and the total transaction amounting to $1,555,279.48.
  • On 12/6/2017 Miles D White, Chairman, sold 276,886 with an average share price of $54.41 per share and the total transaction amounting to $15,065,367.26.
  • On 11/30/2017 Sharon J Bracken, Insider, sold 2,188 with an average share price of $56.12 per share and the total transaction amounting to $122,790.56.
  • On 11/22/2017 Alejandro D Wellisch, Insider, sold 2,153 with an average share price of $55.86 per share and the total transaction amounting to $120,266.58.
  • On 11/17/2017 Brian J Blaser, Insider, sold 23,866 with an average share price of $55.55 per share and the total transaction amounting to $1,325,756.30.
  • On 11/14/2017 Daniel Gesua Sive Salvadori, Insider, sold 71,157 with an average share price of $55.00 per share and the total transaction amounting to $3,913,635.00.
  • On 10/23/2017 Daniel Gesua Sive Salvadori, EVP, sold 96,603 with an average share price of $56.21 per share and the total transaction amounting to $5,430,054.63.

Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
Shares of Abbott Laboratories closed the previous trading session at 62.59 up +0.86 1.39% with shares trading hands.